Verastem (VSTM) Change in Account Payables (2011 - 2026)
Verastem (VSTM) recorded quarterly Change in Account Payables of -$2.8 million in Q1 2026, down 172.9% quarter-over-quarter from $3.9 million in Q4 2025, and down 189.69% on a YoY basis from $3.2 million in Q1 2025.
Verastem (VSTM) Change in Account Payables (2011 - 2026) Analysis & Trends
Verastem's Change in Account Payables history runs 16 years deep, the most recent figure standing at -$2.8 million for Q1 2026.
- In Q1 2026, Change in Account Payables fell 189.69% year-over-year to -$2.8 million; the TTM figure through Mar 2026 stood at $2.4 million (up 1061.2% YoY), while the FY2025 annual figure was $8.4 million, up 366.69% from the prior year.
- Change in Account Payables was -$2.8 million for Q1 2026 at Verastem, down from $3.9 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $3.9 million in Q4 2025 to a low of -$2.8 million in Q1 2026.
- Historically, Change in Account Payables has averaged $429411.8 across 5 years, with a median of $92000.0 in 2022.
- Biggest YoY gain for Change in Account Payables was 13150.0% in 2024; the steepest drop was 450.55% in 2024.
- A 5-year view of Change in Account Payables shows it stood at -$458000.0 in 2022, then surged by 551.09% to $2.1 million in 2023, then sank by 119.94% to -$412000.0 in 2024, then jumped by 1047.57% to $3.9 million in 2025, then sank by 172.9% to -$2.8 million in 2026.
- The last three Change in Account Payables figures came in at -$2.8 million (Q1 2026), $3.9 million (Q4 2025), and $497000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | -2.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.85 Mn |
| Mar 31, 2026 | -2.85 Mn |
| Dec 31, 2025 | 3.90 Mn |
| Dec 31, 2025 | 3.90 Mn |
| Sep 30, 2025 | 497,000.00 |
| Sep 30, 2025 | 497,000.00 |
| Jun 30, 2025 | 848,000.00 |
| Jun 30, 2025 | 848,000.00 |
| Mar 31, 2025 | 3.17 Mn |
| Mar 31, 2025 | 3.17 Mn |
| Dec 31, 2024 | -412,000.00 |
| Dec 31, 2024 | -412,000.00 |
| Sep 30, 2024 | -2.24 Mn |
| Sep 30, 2024 | -2.24 Mn |
| Jun 30, 2024 | -771,000.00 |
| Jun 30, 2024 | -771,000.00 |
| Mar 31, 2024 | 265,000.00 |
| Mar 31, 2024 | 265,000.00 |
| Dec 31, 2023 | 2.07 Mn |
| Dec 31, 2023 | 2.07 Mn |